Comparative risk of fracture in community-dwelling older adults initiating suvorexant versus Z-drugs: results from LIFE study.

This is the first study to show that suvorexant has a generally comparable risk of fracture as compared to Z-drugs. Further research is needed to investigate the potential short-term increased risk of all-cause fracture requiring surgery among suvorexant initiators.